Literature DB >> 1084724

Intestinal bypass operation as a treatment for obesity.

.   

Abstract

The intestinal bypass operation has come into wide use as a method for treating the grossly obese patient. Because it carries risks of morbidity and mortality, it is only suitable for those who meet certain minimal criteria. During the first year after surgery, weight loss varies from 9.1 to 68.0 kg [20 to 150 lb]. These patients have shown improved self-esteem and a reduction in the amount of depression. Mortality for this operation is approximately 4%; many serious complications (liver failure, pulmonary embolus, improper wound healing, severe loss of minerals, and vitamin deficiencies) occur. Hyperoxaluria may result from increased intestinal absorption. A dilated colon (pseudocolonic obstruction) may develop from bacterial overgrowth in the distal segment of the bypassed intestine. Since these serious complications affect 40% of the patients, the operation should be done by trained and skilled physicians who will also be able to manage the long-term postoperative period.

Entities:  

Mesh:

Year:  1976        PMID: 1084724     DOI: 10.7326/0003-4819-85-1-97

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  8 in total

1.  Microbial flora of the stomach after gastric bypass for morbid obesity.

Authors:  Robson K Ishida; Joel Faintuch; Ana M R Paula; Christiane A Risttori; Sabrina N Silva; Elaine S Gomes; Rejane Mattar; Rogerio Kuga; Adriana S Ribeiro; Paulo Sakai; Hermes V Barbeiro; Denise F Barbeiro; Francisco G Soriano; Ivan Cecconello
Journal:  Obes Surg       Date:  2007-06       Impact factor: 4.129

2.  The incidence of urinary tract calculi after small-intestinal bypass operations for treatment of obesity.

Authors:  L Backman; B Nordenwall; D Hallberg
Journal:  Urol Res       Date:  1979-09

3.  A prospective comparison of the jejunoileal and gastric bypass operations for morbid obesity.

Authors:  J A Buckwalter
Journal:  World J Surg       Date:  1977-11       Impact factor: 3.352

4.  Surgical treatment of morbid obesity: mid-term outcomes of the laparoscopic ileal interposition associated to a sleeve gastrectomy in 120 patients.

Authors:  Aureo L DePaula; Alessandro R Stival; Alfredo Halpern; Sergio Vencio
Journal:  Obes Surg       Date:  2011-05       Impact factor: 4.129

5.  [Is the jejunoileal bypass still justified? (author's transl)].

Authors:  G Kieninger; G Müller; G Breucha; R Hoffmann
Journal:  Langenbecks Arch Chir       Date:  1979

6.  Liver injury following jejunoileal bypass. Are there markers?

Authors:  S M Nasrallah; C E Wills; J T Galambos
Journal:  Ann Surg       Date:  1980-12       Impact factor: 12.969

7.  Jejunoileal bypass. Long-term results.

Authors:  C H Organ; M M Cegielski; B J Grabner; H E Keig; J A Saporta
Journal:  Ann Surg       Date:  1980-07       Impact factor: 12.969

Review 8.  Acid-base disturbances in gastrointestinal disease.

Authors:  G O Perez; J R Oster; A Rogers
Journal:  Dig Dis Sci       Date:  1987-09       Impact factor: 3.199

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.